WAT - Waters Corporation
NEXT EARNINGS:
May 12, 2026
EPS Est: $2.35
|
Rev Est: $1.2B
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$401.00
DETAILS
HIGH:
$480.00
LOW:
$350.00
MEDIAN:
$395.00
CONSENSUS:
$401.00
UPSIDE:
22.89%
Market Cap:
19.43B
Volume:
1,108,988
Avg Volume:
837,258
52 Week Range:
275.05-414.15
Sector:
Healthcare
Industry:
Medical - Diagnostics & Research
Beta:
1.18
Last Dividend:
$N/A
Exchange:
NYSE
Country:
US
Employees:
7,600
IPO Date:
1995-11-17
EPS (TTM):
10.80
P/E Ratio:
35.17
Revenue (TTM):
3.17B
Total Assets:
5.08B
Total Debt:
1.41B
Cash & Equiv:
587.83M
Rev Growth (5Y):
6.0%
EPS Growth (5Y):
5.2%
FCF Growth (5Y):
-2.7%
ROCE:
N/A
Debt/Equity:
0.55
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-09 | $4.53 | $4.50 | +0.7% | $932.4M | $928.7M | +0.4% |
| 2025-11-04 | $3.40 | $3.21 | +5.9% | $799.9M | $781.0M | +2.4% |
| 2025-08-04 | $2.95 | $2.94 | +0.3% | $771.3M | $748.7M | +3.0% |
| 2025-05-06 | $2.25 | $2.22 | +1.4% | $661.7M | $654.8M | +1.1% |
| 2025-02-12 | $4.10 | $4.03 | +1.7% | $872.7M | $857.1M | +1.8% |
| 2024-11-01 | $2.93 | $2.68 | +9.3% | $740.3M | $713.0M | +3.8% |
| 2024-07-31 | $2.63 | $2.56 | +2.7% | $708.5M | $700.1M | +1.2% |
| 2024-05-07 | $2.21 | $2.10 | +5.2% | $636.8M | $635.6M | +0.2% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.17B | 2.96B | 2.96B | 2.97B | 2.79B | 2.37B | 2.41B | 2.42B | 2.31B | 2.17B | 2.04B | 1.99B |
| Net Income | 642.63M | 637.83M | 642.23M | 707.75M | 692.84M | 521.57M | 592.20M | 593.79M | 20.31M | 521.50M | 469.05M | 431.62M |
| EPS | 10.80 | 10.75 | 10.87 | 11.80 | 11.25 | 8.40 | 8.76 | 7.71 | 0.25 | 6.46 | 5.70 | 5.12 |
| Total Assets | 5.08B | 4.55B | 4.63B | 3.28B | 3.09B | 2.84B | 2.56B | 3.73B | 5.34B | 4.66B | 4.26B | 3.88B |
| Total Debt | 1.41B | 1.70B | 2.44B | 1.66B | 1.60B | 1.45B | 1.78B | 1.15B | 2.00B | 1.83B | 1.67B | 1.46B |
| Cash & Equivalents | 587.83M | 324.42M | 395.08M | 480.53M | 501.23M | 436.69M | 335.71M | 796.28M | 642.32M | 505.63M | 487.67M | 422.18M |
| Operating Cash Flow | 652.55M | 762.12M | 602.81M | 611.66M | 747.27M | 790.51M | 643.09M | 604.45M | 697.64M | 629.08M | 560.29M | 511.65M |
| Free Cash Flow | 539.81M | 619.64M | 442.18M | 428.20M | 579.01M | 618.12M | 479.26M | 476.88M | 607.17M | 534.11M | 457.28M | 405.40M |
| FCF per Share | 9.07 | 10.44 | 7.48 | 7.14 | 9.40 | 9.95 | 7.09 | 6.19 | 7.61 | 6.61 | 5.55 | 4.81 |
| Book Value | 2.56B | 1.83B | 1.15B | 504.49M | 367.55M | 232.14M | (216.28M) | 1.57B | 2.23B | 2.30B | 2.06B | 1.89B |
| Cash & ST Investments | 587.83M | 325.36M | 395.97M | 481.39M | 569.28M | 443.15M | 337.14M | 1.74B | 3.39B | 2.81B | 2.40B | 2.06B |
| ROC Equity | 0.25 | 0.35 | 0.56 | 1.40 | 1.89 | 2.25 | N/A | 0.38 | 0.01 | 0.23 | 0.23 | 0.23 |